Confirmation on the immunogenicity assay used in the SB4 phase III study: response to the comments by Meacci et al
Annals of the rheumatic diseases.
2016 Jul ;
75 (7) :
e40.
[epub] 20160517
Language English Country United States Media print-electronic
Document type Letter, Comment
Persistent link
https://www.medvik.cz/link/pmid27190097
PubMed
27190097
DOI
10.1136/annrheumdis-2016-209696
PII: S0003-4967(24)01812-0
Knihovny.cz E-resources
- Keywords
- Disease Activity, Inflammation, Treatment,
- MeSH
- Biological Assay * MeSH
- Etanercept therapeutic use MeSH
- Immunoassay MeSH
- Immunosuppressive Agents therapeutic use MeSH
- Antibodies analysis MeSH
- Arthritis, Rheumatoid drug therapy MeSH
- Publication type
- Letter MeSH
- Comment MeSH
- Names of Substances
- Etanercept MeSH
- Immunosuppressive Agents MeSH
- Antibodies MeSH
References provided by Crossref.org
Rheumatology (Oxford, England).
2017 Dec 01 ;
56 (12) :
2093-2101.
